Omar H - Search Results

1

Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods.

Omar H, Said M, Eletreby R, Mehrez M, Bassam M, Abdellatif Z, Hosny A, Megawer S, El Amir M, Yosry A. Omar H, et al. Clin Transplant. 2018 Aug;32(8):e13334. doi: 10.1111/ctr.13334. Epub 2018 Jul 24. Clin Transplant. 2018. PMID: 29935046

2

APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis.

El Serafy MA, Kassem AM, Omar H, Mahfouz MS, El Said El Raziky M. El Serafy MA, et al. Among authors: omar h. Arab J Gastroenterol. 2017 Jun;18(2):51-57. doi: 10.1016/j.ajg.2017.05.005. Epub 2017 Jun 1. Arab J Gastroenterol. 2017. PMID: 28579340 Review.

3

Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients.

Al-Busafi SA, Omar H. Al-Busafi SA, et al. Among authors: omar h. Saudi J Gastroenterol. 2017 Jul-Aug;23(4):263-264. doi: 10.4103/sjg.SJG_136_17. Saudi J Gastroenterol. 2017. PMID: 28721982 Free PMC article. No abstract available.

4

SNPs in the Insulin-Like Growth Factor Gene and Obesity Impact on Colorectal Cancer in Egyptians.

Yosry A, Omran D, Yousef M, Salah M, Omar H, Hamdy S, Shaker O, Elsherif Y, Marie MS. Yosry A, et al. Among authors: omar h. Asian Pac J Cancer Prev. 2017 Nov 26;18(11):2959-2964. doi: 10.22034/APJCP.2017.18.11.2959. Asian Pac J Cancer Prev. 2017. PMID: 29172265 Free PMC article.

5

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.

Omar H, El Akel W, Elbaz T, El Kassas M, Elsaeed K, El Shazly H, Said M, Yousif M, Gomaa AA, Nasr A, AbdAllah M, Korany M, Ismail SA, Shaker MK, Doss W, Esmat G, Waked I, El Shazly Y. Omar H, et al. Aliment Pharmacol Ther. 2018 Feb;47(3):421-431. doi: 10.1111/apt.14428. Epub 2017 Nov 29. Aliment Pharmacol Ther. 2018. PMID: 29193226

6

HCV in Egypt, prevention, treatment and key barriers to elimination.

El Kassas M, Elbaz T, Elsharkawy A, Omar H, Esmat G. El Kassas M, et al. Among authors: omar h. Expert Rev Anti Infect Ther. 2018 Apr;16(4):345-350. doi: 10.1080/14787210.2018.1448709. Epub 2018 Mar 11. Expert Rev Anti Infect Ther. 2018. PMID: 29506418 Review.

7

An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.

El Kassas M, Alboraie M, Omran D, Salaheldin M, Wifi MN, ElBadry M, El Tahan A, Ezzat S, Moaz E, Farid AM, Omar H, Abouelkhair M, Afify S, Elsaeed K, Shazly Y, Doss W, Esmat G. El Kassas M, et al. Among authors: omar h. Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1265-1272. doi: 10.1080/17474124.2018.1476137. Epub 2018 May 24. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29757684

8

Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection.

Elbaz T, Abdo M, Omar H, Hassan EA, Zaghloul AM, Abdel-Samiee M, Moustafa A, Qawzae A, Gamil M, Esmat G. Elbaz T, et al. Among authors: omar h. J Med Virol. 2019 Feb;91(2):272-277. doi: 10.1002/jmv.25287. Epub 2018 Nov 8. J Med Virol. 2019. PMID: 30138531

9

Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort.

Said M, Omar H, Soliman Z, Saad Y, Dabes H, Hamed S, ElSaeed K, ElShazly Y, ElSerafy M. Said M, et al. Among authors: omar h. Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):89-93. doi: 10.1080/17474124.2019.1544070. Epub 2018 Nov 13. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30791838

10

The clinical usefulness of elastography in the evaluation of nonalcoholic fatty liver disease patients: A biopsy-controlled study.

Darweesh SK, Omar H, Medhat E, Abd-Al Aziz RA, Ayman H, Saad Y, Yosry A. Darweesh SK, et al. Among authors: omar h. Eur J Gastroenterol Hepatol. 2019 Aug;31(8):1010-1016. doi: 10.1097/MEG.0000000000001365. Eur J Gastroenterol Hepatol. 2019. PMID: 30807444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

769 results

Search Page